Lombard Odier Asset Management (USA)’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-85,000
| Closed | -$59K | – | 366 |
|
|
2020
Q4 | $59K | Buy |
+85,000
| New | +$59K | ﹤0.01% | 131 |
|
|
2020
Q3 | – | Sell |
-297,183
| Closed | -$1.06M | – | 260 |
|
|
2020
Q2 | $1.06M | Buy |
297,183
+60,000
| +25% | +$215K | 0.07% | 107 |
|
|
2020
Q1 | $901K | Sell |
237,183
-26,354
| -10% | -$100K | 0.09% | 113 |
|
|
2019
Q4 | $793K | Buy |
+263,537
| New | +$793K | 0.07% | 131 |
|